Trial Profile
A single center study investigating ciclosporine A microemulsion in combination with basiliximab and prednisolone and switch to low-dose ciclosporine A and everolimus without steroids in the prevention of transplant nephropathy in pediatric renal allografts recipients.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Jun 2011
Price :
$35
*
At a glance
- Drugs Ciclosporin (Primary) ; Everolimus (Primary)
- Indications Renal transplant rejection
- Focus Adverse reactions
- 22 Jun 2011 New trial record